News

Simple Comorbidity Scale Judged Useful in Leukemia

Publish date: July 9, 2012

 

AT THE ANNUAL CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION

The CLL8 study was sponsored by the GCLLSG with funding from Roche. Dr. Goede has received honoraria from Roche, Mundi-Pharma, and Gilead.

Pages

Recommended Reading

Fertility Preservation No Longer Experimental for Cancer Patients
MDedge Hematology and Oncology
As CT Scans Increase, Concern of Radiation Risk Rises
MDedge Hematology and Oncology
Relapsed/Refractory Leukemia Responds to Experimental Inotuzumab
MDedge Hematology and Oncology
New Data Confirm Safety of Stopping Imatinib in Leukemia
MDedge Hematology and Oncology
Azacitidine-Gemtuzumab Combo Effective in Good-Risk AML
MDedge Hematology and Oncology
FDA Announces Limited Leucovorin Recall
MDedge Hematology and Oncology
FDA Warns of QT Prolongation with Ondansetron Dose
MDedge Hematology and Oncology
Community Oncology Podcast - Ruxolitinib for myelofibrosi
MDedge Hematology and Oncology
New antibody achieves high CR rate in relapsed/refractory adult ALL
MDedge Hematology and Oncology
Despite efficacy, most patients discontinued therapy
MDedge Hematology and Oncology